CME Group Inc (NASDAQ:CME) – Stock analysts at Jefferies Group reduced their FY2017 EPS estimates for CME Group in a research report issued on Tuesday. Jefferies Group analyst D. Fannon now anticipates that the financial services provider will post earnings of $4.74 per share for the year, down from their prior estimate of $4.80. Jefferies Group also issued estimates for CME Group’s Q4 2017 earnings at $1.10 EPS.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. During the same quarter last year, the business earned $1.05 earnings per share. CME Group’s revenue was up 5.8% compared to the same quarter last year.

A number of other equities analysts have also weighed in on the stock. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, September 27th. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $133.00 price target on shares of CME Group in a report on Thursday, September 21st. Royal Bank of Canada lifted their price target on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a report on Monday, October 16th. Barclays lifted their price target on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a report on Tuesday, October 10th. Finally, Wells Fargo & Co lifted their price target on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 4th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $144.22.

Shares of CME Group (NASDAQ CME) opened at $152.21 on Wednesday. CME Group has a 1 year low of $114.82 and a 1 year high of $155.29. The stock has a market cap of $51,358.96, a P/E ratio of 34.51, a P/E/G ratio of 2.03 and a beta of 0.72. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05.

The firm also recently announced a dividend, which was paid on Tuesday, January 16th. Stockholders of record on Thursday, December 28th were paid a $3.50 dividend. The ex-dividend date was Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio (DPR) is currently 59.86%.

In related news, insider Sunil Cutinho sold 2,600 shares of CME Group stock in a transaction on Friday, November 17th. The shares were sold at an average price of $139.57, for a total transaction of $362,882.00. Following the sale, the insider now owns 22,301 shares of the company’s stock, valued at approximately $3,112,550.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO John W. Pietrowicz sold 7,500 shares of CME Group stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the sale, the chief financial officer now directly owns 32,376 shares in the company, valued at approximately $4,904,964. The disclosure for this sale can be found here. In the last three months, insiders sold 42,603 shares of company stock worth $6,250,726. Insiders own 0.57% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in CME. Quadrant Capital Group LLC grew its holdings in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares in the last quarter. Valeo Financial Advisors LLC acquired a new position in CME Group during the 3rd quarter worth $124,000. San Francisco Sentry Investment Group CA acquired a new position in CME Group during the 2nd quarter worth $129,000. People s United Financial Inc. grew its holdings in CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 110 shares in the last quarter. Finally, Mckinley Capital Management LLC Delaware acquired a new position in CME Group during the 2nd quarter worth $150,000. 82.78% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2018/01/19/equities-analysts-offer-predictions-for-cme-group-incs-fy2017-earnings-cme.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Receive News & Stock Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related stocks with our FREE daily email newsletter.